SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-22-036519
Filing Date
2022-07-01
Accepted
2022-07-01 11:39:55
Documents
13
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2021a1_emmaus.htm   iXBRL 10-K/A 47835
  Complete submission text file 0001213900-22-036519.txt   255679

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE emma-20211231.xsd EX-101.SCH 3291
3 XBRL DEFINITION FILE emma-20211231_def.xml EX-101.DEF 15990
4 XBRL LABEL FILE emma-20211231_lab.xml EX-101.LAB 33925
5 XBRL PRESENTATION FILE emma-20211231_pre.xml EX-101.PRE 16926
7 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021a1_emmaus_htm.xml XML 4691
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35527 | Film No.: 221060281
SIC: 2834 Pharmaceutical Preparations